SAMH
PTX

Shanda Asset Management Holdings’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Shanda Asset Management Holdings’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,000
Closed -$2K – 54
2018
Q1 		$2K Hold
1,000
– – ﹤0.01% 39
2017
Q4 		$2K Hold
1,000
– – ﹤0.01% 45
2017
Q3 		$3K Buy
+1,000
New +$3.21K ﹤0.01% 39
2016
Q4 		– Sell
-1,000
Closed -$6K – 29
2016
Q3 		$6K Buy
+1,000
New +$6.16K ﹤0.01% 26

Other funds holding PTX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Shanda Asset Management Holdings's PTX Position: Q2 2018 in Review

Shanda Asset Management Holdings sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q2 2018, closing a stake of 1,000 shares — an estimated $2K sold.

Shanda Asset Management Holdings first reported a position in PTX in Q3 2016 and held it in 4 quarters. The position peaked at $6K in Q3 2016. 29 funds tracked by Wall St. Rank hold PTX as of Q2 2018.

  • Shanda Asset Management Holdings reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q2 2018 after selling out during the quarter.
  • Shanda Asset Management Holdings sold 1,000 Pernix Therapeutics Holdings, Inc. shares in Q2 2018, an estimated $2K.
  • Shanda Asset Management Holdings first reported a position in Pernix Therapeutics Holdings, Inc. in Q3 2016 and held it in 4 quarters.
  • Shanda Asset Management Holdings's Pernix Therapeutics Holdings, Inc. position peaked at $6K in Q3 2016.
  • 29 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2018.

Based on Shanda Asset Management Holdings's 13F filing for Q2 2018, filed 14 Aug 2018.